HealthEquity, Inc. $HQY Stock: William Blair Investment Management LLC Lowers Stake

William Blair Investment Management LLC reduced its holdings in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 1.9% in the third quarter, HoldingsChannel reports. The firm owned 1,740,078 shares of the company’s stock after selling 33,149 shares during the period. William Blair Investment Management LLC’s holdings in HealthEquity were worth $153,927,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in HQY. BlackRock Inc. bought a new position in shares of HealthEquity during the 2nd quarter worth approximately $1,018,621,000. Wasatch Advisors LP grew its position in shares of HealthEquity by 10.5% during the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock worth $719,014,000 after buying an additional 757,801 shares during the period. Dimensional Fund Advisors LP grew its position in shares of HealthEquity by 2.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,627,039 shares of the company’s stock worth $135,957,000 after buying an additional 45,287 shares during the period. Bank of America Corp DE acquired a new stake in shares of HealthEquity during the 2nd quarter worth approximately $103,573,000. Finally, Atalan Capital Partners LP bought a new stake in shares of HealthEquity in the 2nd quarter valued at $82,667,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a research note on Friday, August 28th. Weiss Ratings raised shares of HealthEquity from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, November 2nd. Barclays increased their target price on shares of HealthEquity from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Friday, September 18th. Raymond James Financial restated a “strong-buy” rating on shares of HealthEquity in a report on Thursday, September 3rd. Finally, BMO Capital Markets lifted their price target on shares of HealthEquity from $105.00 to $125.00 and gave the company an “outperform” rating in a research note on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $113.53.

Check Out Our Latest Stock Report on HQY

Insider Buying and Selling

In other HealthEquity news, Director Adrian Dillon sold 7,632 shares of the business’s stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the completion of the sale, the director owned 62,395 shares in the company, valued at approximately $6,527,140.95. The trade was a 10.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.60% of the company’s stock.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $103.46 on Monday. The company has a quick ratio of 2.99, a current ratio of 2.99 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $110.26. The stock’s 50 day moving average is $96.08 and its 200-day moving average is $89.97. The firm has a market capitalization of $8.56 billion, a price-to-earnings ratio of 37.35, a PEG ratio of 1.63 and a beta of 0.22.

HealthEquity (NASDAQ:HQY – Get Free Report) last issued its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The company had revenue of $350.73 million for the quarter, compared to analysts’ expectations of $349.22 million. The firm’s quarterly revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Sell-side analysts forecast that HealthEquity, Inc. will post 3.94 EPS for the current fiscal year.

HealthEquity Profile

(Free Report)

HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.

Featured Stories

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.